Cited by

• Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.

  Zakarija M, McKenzie JM, Munro DS. Zakarija M, et al. J Clin Invest. 1983 Oct;72(4):1352-6. doi: 10.1172/JCI111091. J Clin Invest. 1983. PMID: 6138363 Free PMC article.
• The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.

  Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T. Bliddal H, et al. J Endocrinol Invest. 1983 Aug;6(4):259-62. doi: 10.1007/BF03347586. J Endocrinol Invest. 1983. PMID: 6139399
• Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.

  Heyma P, Harrison LC. Heyma P, et al. J Clin Invest. 1984 Sep;74(3):1090-7. doi: 10.1172/JCI111476. J Clin Invest. 1984. PMID: 6088581 Free PMC article.
• Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.

  Ikeda H, Chiu SC, Kuzuya N, Uchimura H, Nagataki S. Ikeda H, et al. J Endocrinol Invest. 1984 Feb;7(1):1-6. doi: 10.1007/BF03348367. J Endocrinol Invest. 1984. PMID: 6325527
• Autoimmune thyroid disease and pregnancy.

  McGregor AM, Hall R, Richards C. McGregor AM, et al. Br Med J (Clin Res Ed). 1984 Jun 16;288(6433):1780-1. doi: 10.1136/bmj.288.6433.1780. Br Med J (Clin Res Ed). 1984. PMID: 6428542 Free PMC article. No abstract available.